The diabetic retinopathy treatment market attained a value of about USD 6.49 billion in 2023, driven by the increasing prevalence of diabetes across the 8 major markets. Diabetic retinopathy, a complication of diabetes that affects the eyes, is becoming a major concern worldwide due to the rising number of diabetic patients. Advances in treatment options, including anti-VEGF therapies,...

The alternative cancer treatment market is expected to grow at a compound annual growth rate (CAGR) of 17.8% during the forecast period of 2024-2032, driven by the rising incidence of cancer, increased research and innovation in alternative treatments, and the growing preference for holistic and integrative health approaches across the eight major markets. As cancer prevalence continues to rise...